⌘K

Login Start Free

Home/Filings/4/0001278819-04-000061

4//SEC Filing

SMITH MARK L 4

Accession 0001278819-04-000061

CIK 0000072444other

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 10:23 AM ET

Size

5.4 KB

Accession

0001278819-04-000061

Insider Transaction Report

Form 4

Period: 2004-11-30

NABI BIOPHARMACEUTICALSNABI

Sr. VP Fin., CFO, CAO & Treas.

Transactions

Other
Common Stock
2004-11-30$12.30/sh+1,056.911$13,000→ 18,679.79 total

Footnotes (1)

[F1]Voluntarily reported acquisition under the issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3(c).

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NABI BIOPHARMACEUTICALS

CIK 0000072444

Entity typeother

Related Parties

1

filerCIK 0001206467

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 10:23 AM ET
Size: 5.4 KB

View on SEC.gov